Study investigators
Nobukazu Fujimoto, Hidenori, Cancer
SHIGA, HARADA, CROSS, CANCER
The following investigators agreed to be mentioned: Hiroki Shomura (Japan Community Health Care Organization Hokkaido Hospital, Hokkaido), Yasunori Nishida (Keiyukai Sapporo Hospital, Hokkaido), Yasushi Tsuji (Tonan Hospital, Hokkaido), Osamu Sasaki (Miyagi Cancer Center, Miyagi), Naoya Sodeyama (Sendai City Hospital, Miyagi), Yasuhiro Sakamoto (Osaki Citizen Hospital, Miyagi), Yasuhiro Yanagita (Gunma Prefectural Cancer Center, Gunma), Hiroshi Kojima (Ibaraki Prefectural Central Hospital, Ibaraki), Naoto Miyanaga (Mito Saiseikai General Hospital, Ibaraki), Masahiro Kamiga (Hitachi, Ltd., Hitachinaka General Hospital, Ibaraki), Masaharu Shinkai (Tokyo Shinagawa Hospital, Tokyo), Hitoshi Arioka (Yokohama Rosai Hospital, Kanagawa), Kazuhiro Seike (Odawara Municipal Hospital, Kanagawa), Kazuhiro Sato (Nagaoka Red Cross Hospital, Niigata), Koichi Nishi (Ishikawa Prefectural Central Hospital, Ishikawa), Kazuhisa Yoshimoto (Fuji City General Hospital, Shizuoka), Kazutoshi Asano (Shizuoka Saiseikai General Hospital, Shizuoka), Keiji Aizu (Kasugai Municipal Hospital, Aichi), Hibiki Kanda (Omi Medical Center, Shiga), Yukito Adachi (Saiseikai Noe Hospital, Osaka), Hiroyuki Narahara (Hyogo Prefectural Nishinomiya Hospital, Hyogo), Keisuke Tomii (Kobe City Medical Center General Hospital, Hyogo), Tomoe Fukunaga (Japanese Red Cross Society Himeji Hospital, Hyogo), Nobukazu Fujimoto (JOHAS Okayama Rosai Hospital, Okayama), Shoichi Kuyama (National Hospital Organization Iwakuni Clinical Center, Yamaguchi), Hidenori Harada (Yamaguchi University Hospital, Yamaguchi), Ryo Katsuki (National Hospital Organization Ureshino Medical Center, Saga), Minoru Yoshida and Shima Uneda (Japanese Red Cross Kumamoto Hospital, Kumamoto), Kodai Kawamura (Saiseikai Kumamoto Hospital, Kumamoto), and Daisuke Himeji (Miyazaki Prefectural Miyazaki Hospital, Miyazaki).